Biotech Breaks Out As Pharma Starts Looking Past 2031
Is Biotech back?
For much of the past five years, biotech has been a graveyard of broken breakouts and disappointed investors. But that narrative may finally be changing. New highs, renewed acquisition activity and growing enthusiasm around AI-powered drug discovery are beginning to create a more compelling backdrop for the sector. Is biotech finally back? Here are the charts.